Literature DB >> 1703796

IgE-mediated anaphylactic degranulation of isolated human skin mast cells.

A M Dvorak1, W Massey, J Warner, S Kissell, A Kagey-Sobotka, L M Lichtenstein.   

Abstract

Isolated human skin mast cells (HSMC) were prepared and cultured overnight before functional and electron microscopic studies. Mast cell suspensions were examined after stimulation with anti-IgE to produce anaphylactic degranulation or examined in buffer-incubated controls. Histamine release was measured in replicate samples. Control, isolated HSMC studied by electron microscopy were well preserved and fully granulated. Although all granule patterns reported for human mast cells were found, crystal granules were the most prevalent, as is true for HSMC in situ. Individual mast cells containing both crystal and scroll granules occurred. Lipid bodies were rare, as in HSMC in situ. Control, isolated mast cells did not express granule changes associated with either piecemeal degranulation or recovery during wound healing in situ; nor were morphologic changes of anaphylactic degranulation present. Spontaneous histamine release was 0% in control samples. Anaphylactic degranulation of isolated HSMC was accompanied by 24% maximum histamine release and characteristically showed extrusion of altered, membrane-free granules through multiple pores in the plasma membrane to the exterior of the cell. Other morphologic aspects of anaphylactic degranulation, as expressed in isolated human lung mast cells, were also present. These events included granule swelling, fusion, alteration of matrix contents, degranulation channel formation, pore formation, and shedding of granules, membranes, and surface processes. The ultrastructural morphology of isolated HSMC and their IgE-mediated degranulation shows some differences from similar studies of isolated human lung mast cells and of human lung and gut mast cells in biopsy samples. These differences include crystal granules as the predominant granule pattern, minor numbers of lipid bodies, and extrusion of granules during anaphylactic degranulation as characteristic for HSMC. By contrast, isolated human lung and gut mast cells have more scroll granules and particle granules, respectively, and more lipid bodies. In isolated human lung mast cells, anaphylactic degranulation is almost exclusively an intracellular fusion event characterized by the formation of complex degranulation channels within which altered granule matrix materials solubilize. In addition to morphologic differences between mast cells of skin, lung, or gut origin, functional differences have also been reported among mast cells of these organs. The ultrastructural morphology of isolated HSMC is identical to that of skin mast cells in biopsy samples, thereby validating the usefulness of this new source of HSMC for correlative functional and morphologic studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703796

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation.

Authors:  G Raposo; D Tenza; S Mecheri; R Peronet; C Bonnerot; C Desaymard
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

2.  Different activation signals induce distinct mast cell degranulation strategies.

Authors:  Nicolas Gaudenzio; Riccardo Sibilano; Thomas Marichal; Philipp Starkl; Laurent L Reber; Nicolas Cenac; Benjamin D McNeil; Xinzhong Dong; Joseph D Hernandez; Ronit Sagi-Eisenberg; Ilan Hammel; Axel Roers; Salvatore Valitutti; Mindy Tsai; Eric Espinosa; Stephen J Galli
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

Review 3.  Cytokines regulate development of human mast cells from hematopoietic progenitors.

Authors:  Tatsutoshi Nakahata; Hano Toru
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

Review 4.  Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.

Authors:  Peter Valent; Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Michel Arock
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

5.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

6.  Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but not morphine sulfate.

Authors:  J W Verbsky; P K McAllister; D G Malone
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

7.  Human lung-derived mature mast cells cultured alone or with mouse 3T3 fibroblasts maintain an ultrastructural phenotype different from that of human mast cells that develop from human cord blood cells cultured with 3T3 fibroblasts.

Authors:  A M Dvorak; T Furitsu; P Estrella; T Ishizaka
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

Review 8.  Vesicular trafficking and signaling for cytokine and chemokine secretion in mast cells.

Authors:  Ulrich Blank; Iris Karina Madera-Salcedo; Luca Danelli; Julien Claver; Neeraj Tiwari; Elizabeth Sánchez-Miranda; Genaro Vázquez-Victorio; Karla Alina Ramírez-Valadez; Marina Macias-Silva; Claudia González-Espinosa
Journal:  Front Immunol       Date:  2014-09-22       Impact factor: 7.561

Review 9.  Mast cell mediators: their differential release and the secretory pathways involved.

Authors:  Tae Chul Moon; A Dean Befus; Marianna Kulka
Journal:  Front Immunol       Date:  2014-11-14       Impact factor: 7.561

10.  Nanoimaging granule dynamics and subcellular structures in activated mast cells using soft X-ray tomography.

Authors:  Huan-Yuan Chen; Dapi Meng-Lin Chiang; Zi-Jing Lin; Chia-Chun Hsieh; Gung-Chian Yin; I-Chun Weng; Peter Guttmann; Stephan Werner; Katja Henzler; Gerd Schneider; Lee-Jene Lai; Fu-Tong Liu
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.